nach oben

Clinical Rheumatology

Erschienen in:

13.11.2017 | Review Article

Current concepts and unmet needs in psoriatic arthritis

verfasst von: Farrouq Mahmood, Laura C Coates, Philip S Helliwell

Erschienen in: Clinical Rheumatology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Psoriatic arthritis is a chronic inflammatory arthritis that is part of the spondyloarthropathy group of rheumatic diseases and has associated co-morbidities. It can present with various clinical manifestations making diagnosis and treatment challenging, resulting in significant disability and reduced quality of life for patients. Whilst there have been advances in understanding the pathogenic mechanisms of the disease which have resulted in targeted therapies, there is still the need for further studies as some patients fail or are intolerant of current therapies. Better identification of early disease and knowledge of prognostic markers would enable clinicians to initiate appropriate therapy with the expectation that early aggressive treatment will minimise joint damage progression. Improved knowledge of the condition would also enable clinicians to better tailor specific treatment strategies for each of the various clinical domains in psoriatic arthritis.

Ritchlin CT, Colbert RA, Gladman D (2017) Psoriatic arthritis. N Engl J Med 376:957–970CrossRefPubMed

Mease PJ, Armstrong AW (2014) Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs 74(4):423–441CrossRefPubMedPubMedCentral

Huynh DQ, Kavanaugh A (2015) Psoriatic arthritis: current therapy and future approaches. Rheumatology (Oxford) 54(1):20–28

Kavanaugh A, Helliwell P, Ritchlin CT (2016) Psoriatic arthritis and burden of disease: patient perspectives from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey. Rheumatol Ther 3(1):91–102CrossRefPubMedPubMedCentral

Van de Kerkhof PCM, Reich K, Kavanaugh A et al (2015) Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based multinational assessment of psoriasis and psoriatic arthritis survey. J Eur Acad Dermatol Venereol 29(10):2002–2010CrossRefPubMedPubMedCentral

Coates LC, Helliwell P (2016) Psoriatic Arthritis. Oxford Textbook of Rheumatology 4^th edition Chapter 114

Nograles KE, Brasington RD, Bowcock AM (2009) New insights into the pathogenesis and genetics of psoriatic arthritis. Nat ClinPract Rheumatol 5(2):83–91CrossRef

Busse K, Liao W (2010) Which psoriasis patients develop psoriatic arthritis? Psoriasis Forum 16(4):17–25PubMedPubMedCentral

Palazzi C et al (2005) Hepatitis C virus infection in psoriatic arthritis. Arthritis Rheum 53:223–225CrossRefPubMed

10.

FitzGerald O, Haroon M, Giles JT, Winchester R (2015) Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther 17(1):115CrossRefPubMedPubMedCentral

11.

Haroon M, Winchester R, Giles JT et al (2016) Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann Rheum Dis 75:155–162CrossRefPubMed

12.

Cretu D, Gao L, Liang K, Soosaipillai A, Diamandis EP, Chandran V (2017) Novel serum biomarkers differentiate psoriatic arthritis from psoriasis without psoriatic arthritis. Arthritis Care & Research, Accepted Author Manuscript [epub ahead of print]

13.

Kerschbaumer A, Fenzl KH, Erlacher L, Aletaha D (2016) An overview of psoriatic arthritis—epidemiology, clinical features, pathophysiology and novel treatment targets. Wien Klin Wochenschr 128(21):791–795CrossRefPubMedPubMedCentral

14.

McGonagle D (2009) Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol 23:9–13CrossRefPubMed

15.

Gisondi P, Tinazzi I, El-Dalati G et al (2008) Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case–control study. Ann Rheum Dis 67:26–30CrossRefPubMed

16.

Gill T, Asquith M, Rosenbaum JT, Colbert RA (2015) The intestinal microbiome in spondyloarthritis. Curr Opin Rheumatol 27(4):319–325CrossRefPubMedPubMedCentral

17.

Scher JU, Ubeda C, Artacho A et al (2015) Decreased bacterial diversity characterizes an altered gut microbiota in psoriatic arthritis and resembles dysbiosis of inflammatory bowel disease. Arthritis Rheumatol (Hoboken, NJ) 67(1):128–139CrossRef

18.

Coates LC, Moverley AR, McParland L et al (2015) Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised, controlled trial. Lancet (London, England) 386(10012):2489–2498CrossRef

19.

Wilkins RA, Siddle HJ, Redmond AC, Helliwell PS (2016) Plantar forefoot pressures in psoriatic arthritis-related dactylitis: an exploratory study. Clin Rheumatol 35:2333–2338CrossRefPubMedPubMedCentral

20.

Mease PJ, Karki C, Palmer J et al (2017) Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis: results from the Corrona psoriatic arthritis/spondyloarthritis registry. Arthritis Care Res. Accepted Author Manuscript

21.

Mease PJ, Van den Bosch F, Sieper J et al (2011) Performance of 3 enthesitis indices in patients with peripheral spondyloarthritis during treatment with adalimumab. J Rheumatol 38(8):1656–1660CrossRef

22.

Raychaudhuri SP, Wilken R, Sukhov AC et al (2017) Management of psoriatic arthritis: early diagnosis, monitoring of disease severity and cutting edge therapies. J Autoimmun 76:21–37CrossRefPubMed

23.

Siebert S et al (2017) Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups. Sci Rep 7:40473CrossRefPubMedPubMedCentral

24.

Gladman DD (2016) Recent advances in understanding and managing psoriatic arthritis. F1000Research 5:2670CrossRefPubMedPubMedCentral

25.

Poggenborg RP, Pedersen SJ, Eshed I, Sørensen IJ, Møller JM, Madsen OR, Thomsen HS, Østergaard M (2015) Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps towards global inflammation and damage scores of peripheral and axial joints. Rheumatology (Oxford) 54(6):1039–1049CrossRef

26.

Haroon M, Gallagher P, FitzGerald O (2015) Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 74(6):1045–1050. https://doi.org/10.1136/annrheumdis-2013-204858 CrossRefPubMed

27.

Rudwaleit M, van der Heijde D, Landewé R et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25–31CrossRefPubMed

28.

Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673CrossRefPubMed

29.

Congi L, Roussou E (2010) Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria. Clin Exp Rheumatol 28(3):304–310PubMed

30.

Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P (2008) Genetics of psoriasis and psoriatic arthritis: update and future direction (GRAPPA 2007). J Rheumatol 35(7):1449–1453PubMedPubMedCentral

31.

Coates LC, Aslam T, Al Balushi F et al (2013) Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol 168:802–807CrossRefPubMed

32.

De Marco G, Helliwell P, McGonagle D et al (2017) The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes. BMC Musculoskelet Disord 18:303CrossRefPubMedPubMedCentral

33.

Coates LC, Helliwell PS (2016) Psoriasis flare with corticosteroid use in psoriatic arthritis. Br J Dermatol 174:219–221CrossRefPubMed

34.

Marchesoni A, Lubrano E, Cauli A et al (2015) Psoriatic disease: update on traditional disease-modifying antirheumatic drugs. J Rheumatol Suppl 93:61–64CrossRefPubMed

35.

Kavanaugh A, Mease PJ, Gomez-Reino JJ et al (2014) Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor. Ann Rheum Dis 73(6):1020–1026CrossRefPubMedPubMedCentral

36.

Elyoussfi S, Thomas BJ, Ciurtin C (2016) Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies. Rheumatol Int 36:603–612CrossRefPubMedPubMedCentral

37.

Asahina A, Etoh T, Igarashi A et al (2016) Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: a randomized, double-blind, phase 3 study. J Dermatol 43(8):869–880CrossRefPubMedPubMedCentral

38.

Mease P, Hall S, Fitzgerald O et al OP0216 (oral presentation 2017)Efficacy and safety of tofacitinib, an oral janus kinase inhibitor, or adalimumab in patients with active psoriatic arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS): a randomised, placebo-controlled, phase 3 trial. Ann Rheum Dis Suppl 2 76:141–142

39.

Mease PJ, Gottlieb AB, van der Heijde D et al (2017) Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis. Ann Rheum Dis Published Online First: 04 May

Titel: Current concepts and unmet needs in psoriatic arthritis
verfasst von: Farrouq Mahmood
Laura C Coates
Philip S Helliwell
Publikationsdatum: 13.11.2017
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 2/2018
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-017-3908-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Single vagus nerve stimulation reduces early postprandial C-peptide levels but not other hormones or postprandial metabolism

Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA

Health-related quality of life outcomes in patients with rheumatoid arthritis and ankylosing spondylitis after tapering biologic treatment

Prevalence of comorbidities and evaluation of screening in Chinese patients with spondyloarthritis

The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry